TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
FBIO

Fortress Biotech Inc

Healthcare · Biotechnology

2.50$ +2.0% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Fortress Biotech Inc (FBIO)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 64.3% of the shares are freely tradable; institutional investors hold 24.8%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 24.8%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 22.8%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 64.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 21.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 33Mio.

Largest Shareholders

Institutions

Institutions FBIO
Name Stake (%) Shares Change (%) Date
Vanguard Capital Management, LLC 2.90 966,030 +0.0 03/31/2026
Opaleye Management Inc 2.67 890,000 -14.6 06/30/2026
GSA Capital Partners LLP 1.37 458,472 +80.4 06/30/2026
Shikiar Asset Management Inc 0.92 305,469 +0.0 06/30/2026
Geode Capital Management, LLC 0.87 290,255 +10.6 03/31/2026
Northern Trust Corp 0.69 230,053 -4.0 03/31/2026
Two Sigma Investments LLC 0.64 213,786 +8.6 06/30/2026
Susquehanna International Group, LLP 0.63 210,745 -8.3 03/31/2026

Funds

Funds FBIO
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.09 697,802 +0.0 07/31/2026
Vanguard Institutional Extnd Mkt Idx Tr 0.93 311,095 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?